Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
IQVIA Holdings (IQV) is a Top-Ranked Value Stock: Should You Buy?
10:40am, Tuesday, 25'th Feb 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence
09:00am, Monday, 24'th Feb 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences and healthcar
IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025
09:00am, Friday, 21'st Feb 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the
IQVIA Releases 2024 Sustainability Report
10:06am, Thursday, 20'th Feb 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healt
NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
01:36pm, Tuesday, 18'th Feb 2025
ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management.
IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way
03:36am, Sunday, 16'th Feb 2025
IQVIA has seen an increase of 58.97% in its revenues since 2017. In addition, its net profit margin has strengthened since 2018. The CRO market expects to grow at a 7.42% CAGR between 2024 and 2033, w
IQVIA (IQV) International Revenue Performance Explored
10:15am, Friday, 14'th Feb 2025
Explore how IQVIA's (IQV) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
IQVIA Earnings & Revenues Surpass Estimates in Q4, Increase Y/Y
01:51pm, Thursday, 06'th Feb 2025
Growth in the Research and Development, and Technology and Analytics segments aids IQV's top line in the fourth quarter of 2024.
IQVIA Holdings Inc. (IQV) Q4 2024 Earnings Call Transcript
11:58am, Thursday, 06'th Feb 2025
IQVIA Holdings Inc. (NYSE:IQV ) Q4 2024 Earnings Conference Call February 6, 2025 9:00 AM ET Company Participants Kerri Joseph – Senior Vice President, Investor Relations and Treasury Ari Bousbib �
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
11:37am, Thursday, 06'th Feb 2025
On Thursday, IQVIA Holdings Inc IQV reported a fourth adjusted EPS of $3.12, up from $2.84, beating the consensus of $3.11.
Here's What Key Metrics Tell Us About IQVIA (IQV) Q4 Earnings
10:36am, Thursday, 06'th Feb 2025
Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street
IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates
09:10am, Thursday, 06'th Feb 2025
IQVIA Holdings (IQV) came out with quarterly earnings of $3.12 per share, beating the Zacks Consensus Estimate of $3.10 per share. This compares to earnings of $2.84 per share a year ago.
IQVIA beats quarterly results estimates on analytics services demand
08:34am, Thursday, 06'th Feb 2025
Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.
IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance
07:00am, Thursday, 06'th Feb 2025
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to
IQVIA Gears Up to Report Q4 Earnings: What's in Store for the Stock?
01:45pm, Wednesday, 05'th Feb 2025
IQV's top line in the fourth quarter of 2024 is expected to have benefited from the rising use of GenAI to provide crucial insights.
